Mahamaya Lifesciences Ltd

BSE: 544611 · Chemicals & Petrochemicals · 13 announcements

Share price: ₹174.80
Market cap: ₹409.1 Cr
Revenue (annual): ₹329.3 Cr
Net profit (annual): ₹16.72 Cr
P/E (TTM): 24.5×Sector 36.8×
Promoter holding: 56.35%
FII holding: 4.77%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 2 Financial Results 2 Results Update 1 Promoter Buying 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 May 2026 13:13 IST BSE

Results Update

Mahamaya Lifesciences Results Update

Mahamaya Lifesciences reported FY26 revenue of ₹328.87 Crore, representing 24.5% year-on-year growth. EBITDA rose 32.06%, reflecting strong operational performance and improved business momentum.

Value: ₹328.9 Cr

Read the filing ↗